Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.51B | 20.69B | 19.86B | 17.64B | 16.28B | 17.59B | Gross Profit |
7.42B | 7.29B | 6.98B | 6.53B | 5.20B | 5.55B | EBIT |
1.75B | 1.97B | 2.12B | 2.13B | 1.11B | 1.41B | EBITDA |
2.07B | 2.16B | 1.98B | 2.63B | 1.54B | 1.91B | Net Income Common Stockholders |
659.26M | 904.70M | 589.71M | 1.28B | 576.81M | 325.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.33B | 8.07B | 10.17B | 9.84B | 7.19B | 6.90B | Total Assets |
19.05B | 18.32B | 19.52B | 18.77B | 14.74B | 14.80B | Total Debt |
3.90B | 1.02B | 1.34B | 1.69B | 476.45M | 1.47B | Net Debt |
-3.43B | -7.04B | -8.83B | -8.14B | -6.72B | -5.31B | Total Liabilities |
12.94B | 12.10B | 13.53B | 12.89B | 9.39B | 9.90B | Stockholders Equity |
6.09B | 6.21B | 5.66B | 5.63B | 5.13B | 4.70B |
Cash Flow | Free Cash Flow | ||||
0.00 | -17.74M | 2.38B | 2.83B | 1.46B | 1.21B | Operating Cash Flow |
0.00 | 982.90M | 2.88B | 3.22B | 1.81B | 1.86B | Investing Cash Flow |
0.00 | -1.91B | -1.75B | -1.30B | -348.69M | -856.27M | Financing Cash Flow |
0.00 | -1.17B | -793.31M | 721.92M | -1.17B | 475.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥24.48B | 13.02 | 4.03% | 0.69% | 1.90% | ||
76 Outperform | ¥43.22B | 18.04 | 2.40% | 6.70% | 14.08% | ||
75 Outperform | ¥25.24B | 59.39 | 2.20% | 6.29% | -54.28% | ||
70 Outperform | ¥18.64B | 19.15 | 3.36% | 9.70% | 45.81% | ||
70 Neutral | ¥37.06B | 13.74 | 3.56% | 6.41% | 11.83% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% |